Clinical trial
6-Methyl-Prednisolone for Multiple Organ Dysfunction Syndrome
NCT00127985 · Hospital Universitario Principe de Asturias, Other · Unknown status
Key facts
| NCT number | NCT00127985 |
|---|---|
| Title | 6-Methyl-Prednisolone for Multiple Organ Dysfunction Syndrome |
| Official title | The Effect of 6-Methyl-Prednisolone on Organ Dysfunction and Mortality of Patients With Unresolving Multiple Organ Dysfunction Syndrome |
| Acronym | NAIF |
| Lead sponsor | Hospital Universitario Principe de Asturias, Other |
| Collaborators | Pfizer Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Multiple Organ Dysfunction Syndrome |
| Intervention type | Drug |
| Interventions | 6-methyl-prednisolone |
| Enrollment | 240 |
| Start date | Aug 1, 2005 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Aug 9, 2005 |
| Last update posted | May 13, 2008 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- 10–99 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: